Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
29.14
-0.26 (-0.88%)
Nov 12, 2026, 4:00 PM EST - Market closed
Cogent Biosciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Cogent Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $55.82. The average 1-year stock price forecast is 91.56% higher than the current stock price, while the lowest is $45 (+54.43%) and the highest is $61 (+109.33%).
Price Target: $55.82 (+91.56%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cogent Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $55 → $56 | Buy | Maintains | $55 → $56 | +92.18% | Nov 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +54.43% | Nov 6, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $52 | Buy | Maintains | $52 | +78.45% | Nov 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $55 | Buy | Maintains | $55 | +88.74% | Nov 6, 2026 |
| UBS | UBS | Buy Maintains $60 | Buy | Maintains | $60 | +105.90% | Oct 14, 2026 |
Financial Forecast
Revenue This Year
3.85M
Revenue Next Year
284.66M
from 3.85M
Increased by 7,293.31%
EPS This Year
-2.30
from -2.11
EPS Next Year
-1.32
from -2.30
EPS and Forward PE are based on non-GAAP adjusted numbers.